{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:02:12Z","timestamp":1793253732434,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00520-024-08784-w","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T15:02:23Z","timestamp":1723129343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Symptom clusters and network analysis of patients with intermediate and advanced liver cancer treated with targeted immunotherapy"],"prefix":"10.1007","volume":"32","author":[{"given":"Mei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"8784_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"8784_CR2","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","volume":"8","author":"J Qi","year":"2023","unstructured":"Qi J, Li M, Wang L, Hu Y, Liu W, Long Z, Zhou Z, Yin P, Zhou M (2023) National and subnational trends in cancer burden in China, 2005\u201320: an analysis of national mortality surveillance data. Lancet Public Health 8:e943\u2013e955","journal-title":"Lancet Public Health"},{"key":"8784_CR3","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1111\/liv.15101","volume":"42","author":"S Ogasawara","year":"2022","unstructured":"Ogasawara S, Koroki K, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Nakagawa R, Nakamoto S, Muroyama R, Chiba T, Kato N (2022) Changes in therapeutic options for hepatocellular carcinoma in Asia. Liver Int 42:2055\u20132066","journal-title":"Liver Int"},{"key":"8784_CR4","doi-asserted-by":"publisher","first-page":"e002794","DOI":"10.1136\/jitc-2021-002794","volume":"9","author":"TF Greten","year":"2021","unstructured":"Greten TF, Abou-Alfa GK, Cheng AL, Duffy AG, El-Khoueiry AB, Finn RS, Galle PR, Goyal L, He AR, Kaseb AO, Kelley RK, Lencioni R, Lujambio A, Mabry Hrones D, Pinato DJ, Sangro B, Troisi RI, Wilson Woods A, Yau T, Zhu AX, Melero I (2021) Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma. J Immunother Cancer 9:e002794","journal-title":"J Immunother Cancer"},{"key":"8784_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/NCC.0b013e3181b4367e","volume":"33","author":"E Ryu","year":"2010","unstructured":"Ryu E, Kim K, Cho MS, Kwon IG, Kim HS, Fu MR (2010) Symptom clusters and quality of life in Korean patients with hepatocellular carcinoma. Cancer Nurs 33:3\u201310","journal-title":"Cancer Nurs"},{"key":"8784_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/NCC.0000000000000417","volume":"40","author":"MH Chung","year":"2017","unstructured":"Chung MH, Wang SY, Lin CC (2017) Symptom clusters and impact of fatigue and sleep disturbance on symptom experiences of hepatoma patients in Taiwan. Cancer Nurs 40:403\u2013411","journal-title":"Cancer Nurs"},{"key":"8784_CR7","doi-asserted-by":"publisher","first-page":"801981","DOI":"10.3389\/fpubh.2022.801981","volume":"10","author":"H Zou","year":"2022","unstructured":"Zou H, Li M, Lei Q, Luo Z, Xue Y, Yao D, Lai Y, Ung COL, Hu H (2022) Economic burden and quality of life of hepatocellular carcinoma in greater China: a systematic review. Front Public Health 10:801981","journal-title":"Front Public Health"},{"key":"8784_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/SPC.0b013e32835def5b","volume":"7","author":"A Aktas","year":"2013","unstructured":"Aktas A (2013) Cancer symptom clusters: current concepts and controversies. Curr Opin Support Palliat Care 7:38\u201344","journal-title":"Curr Opin Support Palliat Care"},{"key":"8784_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00520-012-1541-5","volume":"21","author":"W Cao","year":"2013","unstructured":"Cao W, Li J, Hu C, Shen J, Liu X, Xu Y, Ye Z (2013) Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China. Support Care Cancer 21:475\u2013483","journal-title":"Support Care Cancer"},{"key":"8784_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4040\/jkan.2009.39.5.683","volume":"39","author":"MS Cho","year":"2009","unstructured":"Cho MS, Kwon IG, Kim HS, Kim K, Ryu E (2009) Identification and validation of symptom clusters in patients with hepatocellular carcinoma. J Korean Acad Nurs 39:683\u2013692","journal-title":"J Korean Acad Nurs"},{"key":"8784_CR11","unstructured":"Guanhong C, Huijuan L, Xiaorong L, Wei Q, Linbo W, Nursing SO, University F (2014) Comparative analysis of symptom cluster in patients after transcatheterhepatic chemoembolization for primary hepatic carcinoma. J Nurs Sci 29:15\u201318"},{"key":"8784_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fpsyt.2015.00117","volume":"6","author":"EI Fried","year":"2015","unstructured":"Fried EI, Boschloo L, van Borkulo CD, Schoevers RA, Romeijn JW, Wichers M, de Jonge P, Nesse RM, Tuerlinckx F, Borsboom D (2015) Commentary: \u201cConsistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.\u201d Front Psychiatry 6:117","journal-title":"Front Psychiatry"},{"key":"8784_CR13","first-page":"91","volume":"37","author":"Z Yang","year":"2022","unstructured":"Yang Z, Zhu Z, Hu Y, Wen H, Zhang L, Fu Y, Wu B (2022) A review of network approach in symptom management. J Nurs Sci 37:91\u201394","journal-title":"J Nurs Sci"},{"key":"8784_CR14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s00520-016-3527-1","volume":"25","author":"M Browall","year":"2017","unstructured":"Browall M, Brandberg Y, Nasic S, Rydberg P, Bergh J, Ryden A, Xie H, Eriksson I, Wengstrom Y (2017) A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment. Support Care Cancer 25:1423\u20131429","journal-title":"Support Care Cancer"},{"key":"8784_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/wps.20375","volume":"16","author":"D Borsboom","year":"2017","unstructured":"Borsboom D (2017) A network theory of mental disorders. World Psychiatry 16:5\u201313","journal-title":"World Psychiatry"},{"key":"8784_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/00273171.2019.1614898","volume":"56","author":"PJ Jones","year":"2021","unstructured":"Jones PJ, Ma R, McNally RJ (2021) Bridge centrality: a network approach to understanding comorbidity. Multivariate Behav Res 56:353\u2013367","journal-title":"Multivariate Behav Res"},{"key":"8784_CR17","doi-asserted-by":"publisher","first-page":"1236129","DOI":"10.3389\/fonc.2023.1236129","volume":"13","author":"J Fang","year":"2023","unstructured":"Fang J, Wong CL, Liu CQ, Huang HY, Qi YS, Xu LL, Wang MX, Lin Y (2023) Identifying central symptom clusters and correlates in children with acute leukemia undergoing chemotherapy: a network analysis. Front Oncol 13:1236129","journal-title":"Front Oncol"},{"key":"8784_CR18","doi-asserted-by":"publisher","first-page":"151651","DOI":"10.1016\/j.soncn.2024.151651","volume":"40","author":"Y Luo","year":"2024","unstructured":"Luo Y, Luo J, Su Q, Yang Z, Miao J, Zhang L (2024) Exploring central and bridge symptoms in patients with lung cancer: a network analysis. Semin Oncol Nurs 40:151651","journal-title":"Semin Oncol Nurs"},{"key":"8784_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00520-023-08288-z","volume":"32","author":"B Shang","year":"2023","unstructured":"Shang B, Bian Z, Luo C, Lv F, Wu J, Lv S, Wei Q (2023) Exploring the dynamics of perioperative symptom networks in colorectal cancer patients: a cross-lagged panel network analysis. Support Care Cancer 32:62","journal-title":"Support Care Cancer"},{"key":"8784_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10865-019-00084-7","volume":"43","author":"MPJ Schellekens","year":"2020","unstructured":"Schellekens MPJ, Wolvers MDJ, Schroevers MJ, Bootsma TI, Cramer AOJ, van der Lee ML (2020) Exploring the interconnectedness of fatigue, depression, anxiety and potential risk and protective factors in cancer patients: a network approach. J Behav Med 43:553\u2013563","journal-title":"J Behav Med"},{"key":"8784_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3758\/s13428-017-0862-1","volume":"50","author":"S Epskamp","year":"2018","unstructured":"Epskamp S, Borsboom D, Fried EI (2018) Estimating psychological networks and their accuracy: a tutorial paper. Behav Res Methods 50:195\u2013212","journal-title":"Behav Res Methods"},{"key":"8784_CR22","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/0959-8049(94)90182-1","volume":"30A","author":"RK Portenoy","year":"1994","unstructured":"Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L et al (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A:1326\u20131336","journal-title":"Eur J Cancer"},{"key":"8784_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jpainsymman.2007.12.019","volume":"37","author":"KK Cheng","year":"2009","unstructured":"Cheng KK, Wong EM, Ling WM, Chan CW, Thompson DR (2009) Measuring the symptom experience of Chinese cancer patients: a validation of the Chinese version of the memorial symptom assessment scale. J Pain Symptom Manag 37:44\u201357","journal-title":"J Pain Symptom Manag"},{"key":"8784_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jpainsymman.2007.11.011","volume":"36","author":"HJ Kim","year":"2008","unstructured":"Kim HJ, Barsevick AM, Tulman L, McDermott PA (2008) Treatment-related symptom clusters in breast cancer: a secondary analysis. J Pain Symptom Manag 36:468\u2013479","journal-title":"J Pain Symptom Manag"},{"key":"8784_CR25","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1038\/s41598-018-36973-1","volume":"9","author":"N Papachristou","year":"2019","unstructured":"Papachristou N, Barnaghi P, Cooper B, Kober KM, Maguire R, Paul SM, Hammer M, Wright F, Armes J, Furlong EP, McCann L, Conley YP, Patiraki E, Katsaragakis S, Levine JD, Miaskowski C (2019) Network analysis of the multidimensional symptom experience of oncology. Sci Rep 9:2258","journal-title":"Sci Rep"},{"key":"8784_CR26","doi-asserted-by":"publisher","unstructured":"Wang K, Diao M, Yang Z, Salvador JT, Zhang Y (2023) Identification of core symptom cluster in patients with digestive cancer: a network analysis. Cancer Nurs.\u00a0https:\/\/doi.org\/10.1097\/NCC.0000000000001280","DOI":"10.1097\/NCC.0000000000001280"},{"key":"8784_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.apjon.2021.12.001","volume":"9","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Xing W, Hu Y, Wu B, So WKW (2022) Paradigm shift: moving from symptom clusters to symptom networks. Asia Pac J Oncol Nurs 9:5\u20136","journal-title":"Asia Pac J Oncol Nurs"},{"key":"8784_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3322\/caac.21704","volume":"72","author":"S Elad","year":"2022","unstructured":"Elad S, Yarom N, Zadik Y, Kuten-Shorrer M, Sonis ST (2022) The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA Cancer J Clin 72:57\u201377","journal-title":"CA Cancer J Clin"},{"key":"8784_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-018-0384-3","volume":"19","author":"M Lacouture","year":"2018","unstructured":"Lacouture M, Sibaud V (2018) Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails. Am J Clin Dermatol 19:31\u201339","journal-title":"Am J Clin Dermatol"},{"key":"8784_CR30","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00520-017-3629-4","volume":"25","author":"E Vigarios","year":"2017","unstructured":"Vigarios E, Epstein JB, Sibaud V (2017) Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Support Care Cancer 25:1713\u20131739","journal-title":"Support Care Cancer"},{"key":"8784_CR31","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.3390\/ijms24098188","volume":"24","author":"A Villa","year":"2023","unstructured":"Villa A, Kuten-Shorrer M (2023) Pathogenesis of oral toxicities associated with targeted therapy and immunotherapy. Int J Mol Sci 24:8188","journal-title":"Int J Mol Sci"},{"key":"8784_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1601-0825.2011.01788.x","volume":"17","author":"DD Mosel","year":"2011","unstructured":"Mosel DD, Bauer RL, Lynch DP, Hwang ST (2011) Oral complications in the treatment of cancer patients. Oral Dis 17:550\u2013559","journal-title":"Oral Dis"},{"key":"8784_CR33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s00520-023-08012-x","volume":"31","author":"M Hannon","year":"2023","unstructured":"Hannon M, Shaw A, Connolly M, Davies A (2023) Taste disturbance in patients with advanced cancer: a scoping review of clinical features and complications. Support Care Cancer 31:562","journal-title":"Support Care Cancer"},{"key":"8784_CR34","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1007\/s00520-020-05903-1","volume":"29","author":"A Davies","year":"2021","unstructured":"Davies A, Buchanan A, Todd J, Gregory A, Batsari KM (2021) Oral symptoms in patients with advanced cancer: an observational study using a novel oral symptom assessment scale. Support Care Cancer 29:4357\u20134364","journal-title":"Support Care Cancer"},{"key":"8784_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3322\/caac.21596","volume":"70","author":"LB Kennedy","year":"2020","unstructured":"Kennedy LB, Salama AKS (2020) A review of cancer immunotherapy toxicity. CA Cancer J Clin 70:86\u2013104","journal-title":"CA Cancer J Clin"},{"key":"8784_CR36","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s00520-017-3802-9","volume":"25","author":"BL Rapoport","year":"2017","unstructured":"Rapoport BL, van Eeden R, Sibaud V, Epstein JB, Klastersky J, Aapro M, Moodley D (2017) Supportive care for patients undergoing immunotherapy. Support Care Cancer 25:3017\u20133030","journal-title":"Support Care Cancer"},{"key":"8784_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/CCO.0000000000000290","volume":"28","author":"V Sibaud","year":"2016","unstructured":"Sibaud V, Meyer N, Lamant L, Vigarios E, Mazieres J, Delord JP (2016) Dermatologic complications of anti-PD-1\/PD-L1 immune checkpoint antibodies. Curr Opin Oncol 28:254\u2013263","journal-title":"Curr Opin Oncol"},{"key":"8784_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2021.07.076","volume":"86","author":"YS Roh","year":"2022","unstructured":"Roh YS, Choi J, Sutaria N, Kwatra SG (2022) Itch: epidemiology, clinical presentation, and diagnostic workup. J Am Acad Dermatol 86:1\u201314","journal-title":"J Am Acad Dermatol"},{"key":"8784_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/01.j.pain.0000460305.41078.7d","volume":"156","author":"A Narayana","year":"2015","unstructured":"Narayana A, Katz N, Shillington AC, Stephenson JJ, Harshaw Q, Frye CB, Portenoy RK (2015) National breakthrough pain study: prevalence, characteristics, and associations with health outcomes. Pain 156:252\u2013259","journal-title":"Pain"},{"key":"8784_CR40","doi-asserted-by":"publisher","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","volume":"17","author":"RA Swarm","year":"2019","unstructured":"Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, Greenlee H, Hansen E, Kamal AH, Kamdar MM, LeGrand S, Mackey S, McDowell MR, Moryl N, Nabell LM, Nesbit S, O\u2019Connor N, Rabow MW, Rickerson E, Shatsky R, Sindt J, Urba SG, Youngwerth JM, Hammond LJ, Gurski LA (2019) Adult cancer pain, version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 17:977\u20131007","journal-title":"J Natl Compr Canc Netw"},{"key":"8784_CR41","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","volume":"26","author":"J Naidoo","year":"2015","unstructured":"Naidoo J, Page DB, Li BT, Connell LC, Schindler K, Lacouture ME, Postow MA, Wolchok JD (2015) Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol 26:2375\u20132391","journal-title":"Ann Oncol"},{"key":"8784_CR42","doi-asserted-by":"publisher","first-page":"100474","DOI":"10.1016\/j.esmoop.2022.100474","volume":"7","author":"I Kiss","year":"2022","unstructured":"Kiss I, Kuhn M, Hrusak K, Buchler T (2022) Incidence of fatigue associated with immune checkpoint inhibitors in patients with cancer: a meta-analysis. ESMO Open 7:100474","journal-title":"ESMO Open"},{"key":"8784_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/PPO.0000000000000396","volume":"25","author":"NM Arring","year":"2019","unstructured":"Arring NM, Barton DL, Brooks T, Zick SM (2019) Integrative therapies for cancer-related fatigue. Cancer J 25:349\u2013356","journal-title":"Cancer J"},{"key":"8784_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00520-022-07549-7","volume":"31","author":"GB Penna","year":"2023","unstructured":"Penna GB, Otto DM, da Silva TC, Pedroni AS, Macagnan FE (2023) Physical rehabilitation for the management of cancer-related fatigue during cytotoxic treatment: a systematic review with meta-analysis. Support Care Cancer 31:129","journal-title":"Support Care Cancer"},{"key":"8784_CR45","doi-asserted-by":"publisher","first-page":"10421","DOI":"10.1007\/s00520-022-07389-5","volume":"30","author":"HJ Zhou","year":"2022","unstructured":"Zhou HJ, Wang T, Xu YZ, Chen YN, Deng LJ, Wang C, Chen JX, Tan JB (2022) Effects of exercise interventions on cancer-related fatigue in breast cancer patients: an overview of systematic reviews. Support Care Cancer 30:10421\u201310440","journal-title":"Support Care Cancer"},{"key":"8784_CR46","doi-asserted-by":"publisher","first-page":"17341","DOI":"10.1038\/s41598-023-44655-w","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Cheng Q, Zhu X, Lin S, Xiang H, Lu W (2023) The relationship of exercise and cancer-related fatigue in patients with advanced liver cancer: a cross-sectional study. Sci Rep 13:17341","journal-title":"Sci Rep"},{"key":"8784_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/1756283X15618131","volume":"9","author":"P Singh","year":"2016","unstructured":"Singh P, Yoon SS, Kuo B (2016) Nausea: a review of pathophysiology and therapeutics. Therap Adv Gastroenterol 9:98\u2013112","journal-title":"Therap Adv Gastroenterol"},{"key":"8784_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00520-023-07879-0","volume":"31","author":"A Molassiotis","year":"2023","unstructured":"Molassiotis A, Zhao IY, Crichton M, Olver I, Fleury M, Giusti R, Scotte F, Affronti ML (2023) Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic review. Support Care Cancer 31:413","journal-title":"Support Care Cancer"},{"key":"8784_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00520-018-4464-y","volume":"27","author":"Y Razvi","year":"2019","unstructured":"Razvi Y, Chan S, McFarlane T, McKenzie E, Zaki P, DeAngelis C, Pidduck W, Bushehri A, Chow E, Jerzak KJ (2019) ASCO, NCCN, MASCC\/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients. Support Care Cancer 27:87\u201395","journal-title":"Support Care Cancer"},{"key":"8784_CR50","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1007\/s00520-020-05481-2","volume":"28","author":"X Tian","year":"2020","unstructured":"Tian X, Tang RY, Xu LL, Xie W, Chen H, Pi YP, Chen WQ (2020) Progressive muscle relaxation is effective in preventing and alleviating of chemotherapy-induced nausea and vomiting among cancer patients: a systematic review of six randomized controlled trials. Support Care Cancer 28:4051\u20134058","journal-title":"Support Care Cancer"},{"key":"8784_CR51","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00520-023-07976-0","volume":"31","author":"C Xiao","year":"2023","unstructured":"Xiao C, Qin M, Xia H, Xing Q, Wang D, Qian W (2023) Effects of PC6 acupressure on acute and delayed nausea and vomiting induced by chemotherapy in patients with malignant neoplasm: a meta-analysis. Support Care Cancer 31:510","journal-title":"Support Care Cancer"},{"key":"8784_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jand.2023.09.003","volume":"124","author":"M Crichton","year":"2024","unstructured":"Crichton M, Marshall S, Isenring E, Lohning A, McCarthy AL, Molassiotis A, Bird R, Shannon C, Koh A, McPherson I, Marx W (2024) Effect of a standardized ginger root powder regimen on chemotherapy-induced nausea and vomiting: a multicenter, double-blind, placebo-controlled randomized trial. J Acad Nutr Diet 124:313-330 e316","journal-title":"J Acad Nutr Diet"},{"key":"8784_CR53","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.3389\/fpsyg.2019.02448","volume":"10","author":"D Castro","year":"2019","unstructured":"Castro D, Ferreira F, de Castro I, Rodrigues AR, Correia M, Ribeiro J, Ferreira TB (2019) The differential role of central and bridge symptoms in deactivating psychopathological networks. Front Psychol 10:2448","journal-title":"Front Psychol"},{"key":"8784_CR54","doi-asserted-by":"publisher","first-page":"103440","DOI":"10.1016\/j.brat.2019.103440","volume":"122","author":"L Boschloo","year":"2019","unstructured":"Boschloo L, Cuijpers P, Karyotaki E, Berger T, Moritz S, Meyer B, Klein JP (2019) Symptom-specific effectiveness of an Internet-based intervention in the treatment of mild to moderate depressive symptomatology: the potential of network estimation techniques. Behav Res Ther 122:103440","journal-title":"Behav Res Ther"},{"key":"8784_CR55","doi-asserted-by":"publisher","first-page":"598317","DOI":"10.3389\/fpsyt.2021.598317","volume":"12","author":"T Kaiser","year":"2021","unstructured":"Kaiser T, Boschloo L, Berger T, Meyer B, Spath-Nellissen C, Schroder J, Hohagen F, Moritz S, Klein JP (2021) Maintaining outcomes of Internet-delivered cognitive-behavioral therapy for depression: a network analysis of follow-up effects. Front Psychiatry 12:598317","journal-title":"Front Psychiatry"},{"key":"8784_CR56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10862-021-09880-5","volume":"43","author":"D Konac","year":"2021","unstructured":"Konac D, Young KS, Lau J, Barker ED (2021) Comorbidity between depression and anxiety in adolescents: bridge symptoms and relevance of risk and protective factors. J Psychopathol Behav Assess 43:583\u2013596","journal-title":"J Psychopathol Behav Assess"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08784-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08784-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08784-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T16:02:33Z","timestamp":1723132953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08784-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["8784"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08784-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by the Ethics Committee of the Third Affiliated Hospital of Naval Medical University, ensuring that all aspects of the research were ethical and in compliance with regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants involved in the study provided informed consent, demonstrating a voluntary and informed decision to participate in the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"580"}}